Allogene Therapeutics, Inc. (ALLO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 273.29M | 257.75M | 260.72M | 282.65M | 291.58M | 303.39M | 304.42M | 457.12M | 395.36M | 459.12M | 473.45M | 502.1M |
| Cash & Short-Term Investments | 266.89M | 250.21M | 252.19M | 273.12M | 280.04M | 292.48M | 291.56M | 444.63M | 384.86M | 448.7M | 465.5M | 491.96M |
| Cash Only | 30.31M | 51.69M | 37.81M | 52.33M | 42.45M | 75.22M | 51.24M | 170.67M | 51.04M | 83.16M | 69.25M | 154.76M |
| Short-Term Investments | 236.58M | 198.52M | 214.38M | 220.79M | 237.59M | 217.26M | 240.32M | 273.96M | 333.82M | 365.54M | 396.26M | 337.2M |
| Accounts Receivable | 1.3M | 1.5M | 2.1M | 0 | 0 | 0 | 0 | 2M | 1.7M | 0 | 1.6M | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | 7.03K | - | 6.69K | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.6M | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.11M | 6.04M | 6.42M | 9.54M | 11.53M | 10.91M | 12.85M | 10.5M | 0 | 10.42M | 7.95M | 10.14M |
| Total Non-Current Assets | 122.67M | 158.16M | 179.05M | 187.94M | 216.41M | 245.32M | 284.7M | 189.76M | 190.99M | 183.72M | 238.87M | 268.87M |
| Property, Plant & Equipment | 108.84M | 112.73M | 116.83M | 120.82M | 127.07M | 131.26M | 135.3M | 150.47M | 160.41M | 163.18M | 181.47M | 186.7M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | 0.00x | -0.00x | 0.00x | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 10.29M | 8.04M | 35.24M | 29.51M | 55.51M | 80.67M | 111.82M | 11.43M | 25.41M | 3.65M | 47.83M | 62.5M |
| Other Non-Current Assets | 3.53M | 37.39M | 26.98M | 37.6M | 33.83M | 33.39M | 37.58M | 27.87M | 5.16M | 16.9M | 9.58M | 19.67M |
| Total Assets | 395.96M | 415.9M | 439.77M | 470.59M | 507.98M | 548.71M | 589.12M | 646.88M | 586.35M | 642.84M | 712.33M | 770.97M |
| Asset Turnover | - | - | - | - | - | - | - | - | 0.00x | -0.00x | 0.00x | 0.00x |
| Asset Growth % | -22.05% | -24.2% | -25.35% | -27.25% | -13.37% | -14.64% | -17.3% | -16.1% | -21.49% | -21.76% | -19.74% | -18.64% |
| Total Current Liabilities | 28.33M | 32.51M | 31.83M | 31.68M | 30.02M | 35.52M | 32.57M | 37.3M | 30.89M | 37.08M | 37.64M | 54.72M |
| Accounts Payable | 4.93M | 4.27M | 3.7M | 4.85M | 5.06M | 5.39M | 5.51M | 12.94M | 5.78M | 5.9M | 6.21M | 10.23M |
| Days Payables Outstanding | 144.35 | 119.91 | 12.62 | - | 151.77 | 155.09 | - | - | 149.44 | - | 211.64 | - |
| Short-Term Debt | 8.42M | 0 | 8.01M | 0 | 0 | 0 | 0 | 7.22M | 6.93M | 0 | 6.58M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 86K | 86K | 236K | 229K |
| Other Current Liabilities | 14.98M | 20.04M | 20.04M | 0 | 0 | 12.15M | 0 | -7.22M | -6.93M | 12.66M | -6.58M | 0 |
| Current Ratio | 9.65x | 7.93x | 8.19x | 8.92x | 9.71x | 8.54x | 9.35x | 12.25x | 12.80x | 12.38x | 12.58x | 9.18x |
| Quick Ratio | 9.65x | 7.93x | 8.19x | 8.92x | 9.71x | 8.54x | 9.35x | 12.25x | 12.80x | 12.38x | 12.62x | 9.18x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 88.75M | 90.85M | 92.61M | 94.36M | 92.57M | 91.01M | 92.8M | 94.54M | 94.09M | 93.53M | 91.59M | 93.34M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 72.63M | 75.05M | 77.13M | 79.24M | 81.29M | 83.25M | 85.14M | 86.99M | 88.92M | 88.35M | 90.1M | 91.82M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 16.12M | 15.8M | 15.47M | 15.12M | 11.28M | 7.76M | 7.67M | 7.55M | 5.17M | 5.18M | 1.49M | 1.52M |
| Total Liabilities | 117.08M | 123.36M | 124.44M | 126.03M | 122.59M | 126.53M | 125.37M | 131.84M | 124.98M | 130.6M | 129.22M | 148.06M |
| Total Debt | 81.05M | 83.25M | 85.14M | 79.24M | 81.29M | 90.76M | 85.14M | 94.21M | 95.85M | 95.12M | 96.68M | 91.82M |
| Net Debt | 50.74M | 31.57M | 47.33M | 26.91M | 38.84M | 15.54M | 33.9M | -76.46M | 44.81M | 11.97M | 27.43M | -62.94M |
| Debt / Equity | 0.29x | 0.28x | 0.27x | 0.23x | 0.21x | 0.21x | 0.18x | 0.18x | 0.21x | 0.19x | 0.17x | 0.15x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -153.64x | -135.48x | -119.35x | -189.09x | -397.22x | -733.52x | -661.93x | - | - | - | - | - |
| Total Equity | 278.88M | 292.54M | 315.33M | 344.56M | 385.39M | 422.18M | 463.75M | 515.04M | 461.37M | 512.23M | 583.1M | 622.91M |
| Equity Growth % | -27.64% | -30.71% | -32% | -33.1% | -16.47% | -17.58% | -20.47% | -17.32% | -22.1% | -23.19% | -21.2% | -22.33% |
| Book Value per Share | 1.16 | 1.33 | 1.42 | 1.57 | 1.79 | 2.00 | 2.22 | 2.71 | 2.73 | 3.04 | 3.48 | 4.24 |
| Total Shareholders' Equity | 278.88M | 292.54M | 315.33M | 344.56M | 385.39M | 422.18M | 463.75M | 515.04M | 461.37M | 512.23M | 583.1M | 622.91M |
| Common Stock | 245K | 229K | 223K | 220K | 219K | 212K | 210K | 209K | 170K | 169K | 168K | 167K |
| Retained Earnings | -2.05B | -2.01B | -1.97B | -1.93B | -1.88B | -1.82B | -1.76B | -1.69B | -1.63B | -1.56B | -1.47B | -1.41B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -183K | 269K | 235K | -45K | 43K | -89K | 157K | -780K | -927K | -955K | -2.41M | -3.85M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |